Splice-Switching Antisense Oligonucleotides for the Treatment of Cystic Fibrosis

Status

Published

on 12 Feb 2021

Year of Creation

2020

Wren Ellen Michaels

Registration Number

TX0008951551

on 12 Feb 2021

The U.S. Copyright record (Registration Number: TX0008951551) dated 12 Feb 2021, pertains to an electronic file (eService) titled "Splice-Switching Antisense Oligonucleotides for the Treatment of Cystic Fibrosis" created in 2020. The copyright holder is Wren Ellen Michaels, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Wren Ellen Michaels.

Wren Ellen Michaels

Application Details

Registration Number

TX0008951551

Registration Date

2/12/2021

Year of Creation

2020

Agency Marc Code

DLC-CO

Record Status

New

Physical Description

Electronic file (eService)

First Publication Nation

United States

ISBN

9798691214936

Preexisting Material

previously published text of Chapter 1

Personal Authors

Wren Ellen Michaels

Notes

Local Copyright Note: C.O. correspondence

Material Matter Claimed Note: new and revised text

Statements

Application Title Statement: Splice-Switching Antisense Oligonucleotides for the Treatment of Cystic Fibrosis

Author Statement: Wren Ellen Michaels Domicile: United States Citizenship: United States Authorship: text

Notes

Local Copyright Note: C.O. correspondence

Material Matter Claimed Note: new and revised text

Statements

Application Title Statement: Splice-Switching Antisense Oligonucleotides for the Treatment of Cystic Fibrosis

Author Statement: Wren Ellen Michaels Domicile: United States Citizenship: United States Authorship: text

Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

Show terms & conditions

Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.